Related Experiment Videos
Piperacillin versus clindamycin plus gentamicin for pelvic infections
Abstract:
Piperacillin, a new semisynthetic penicillin, has broad spectrum activity against most clinically important aerobic and anaerobic bacteria. In the present study, piperacillin was compared with a combination of clindamycin and gentamicin for the treatment of 83 women with pelvic infection (42 with endometritis, 29 with posthysterectomy cuff infections, 11 with acute salpingitis, and one with a wound infection). There were 179 bacterial isolates, 98 (53%) aerobic and 81 (45%) anaerobic. Of the 42 patients treated with piperacillin, there were three (7.1%) clinical failures compared with one (2.4%) in the 41 patients treated with clindamycin-gentamicin. A single drug, piperacillin, was shown to be as safe and effective as the combined clindamycin plus gentamicin therapy for pelvic infections.
Insights
Piperacillin offers broad-spectrum antibacterial activity. This study found piperacillin as safe and effective as clindamycin-gentamicin for treating pelvic infections in women.
Area of Science:
- Pharmacology
- Infectious Diseases
- Bacteriology
Background:
- Pelvic infections involve aerobic and anaerobic bacteria.
- Current treatments often combine multiple antibiotics.
Purpose of the Study:
- To compare the efficacy and safety of piperacillin versus clindamycin-gentamicin for pelvic infections.
- To evaluate piperacillin's effectiveness as a single-agent therapy.
Main Methods:
- A comparative study involving 83 women with various pelvic infections.
- Bacterial isolates were identified and characterized for aerobic and anaerobic profiles.
- Patients were randomized to receive either piperacillin or a combination of clindamycin and gentamicin.
Main Results:
- Piperacillin demonstrated broad-spectrum activity against 179 bacterial isolates (53% aerobic, 45% anaerobic).
- Clinical failure rates were 7.1% for piperacillin (3/42) and 2.4% for clindamycin-gentamicin (1/41).
- Piperacillin showed comparable safety and efficacy to the combination therapy.
Conclusions:
- Piperacillin is a safe and effective single-agent treatment for pelvic infections.
- It provides a viable alternative to combination antibiotic therapy for these conditions.